Plain-language summaries people can actually read
Plain-language summaries of publications, EU Clinical Trials Regulation lay summaries and visual abstracts, written for patients and the public and traced line by line to the source.
- Free sample draft in 3 working days
- 3 review rounds included
- NDA before confidential file sharing
- Response within 24 hours
- US contract with Neucite LLC
Choose the right summary format
Publication PLS: start from the paper and target journal. Trial lay summary: start from the trial report, audience and required languages. Visual abstract: start from the key result and intended format.
Within 24 hours
We respond to your enquiry within 24 hours. A scoped proposal follows within 24 hours of a complete brief. If a specialist discussion is needed, our first reply identifies the missing inputs and agrees the proposal date.
Within three working days
One agreed free sample per organisation is delivered within three working days after the brief, source material and any required NDA are complete.
Dates agreed before paid work
Your proposal states the fee, inputs, first-draft date, review milestones and final delivery. Work starts after you approve the scope and fee. Delivery dates depend on the document and source readiness; the 24-hour promise is for our response, not a completed manuscript.
All dollar prices on these pages are USD. Tell us your country, time zone and source/output languages; we confirm any translation, local review and invoicing requirements in the quote. Confidential files are exchanged after the NDA and secure sharing route are agreed.
One result, two reading styles
Illustrative wording only; this is not a trial result or client sample.
Technical wording
The study evaluated treatment tolerability in adults over the planned follow-up period.
Plain-language wording
The researchers checked how well adults could take the treatment during the study, including any unwanted effects.
Source check
The final wording is checked against the actual paper or report. We do not add benefits or conclusions that the source does not support.
Every audience outside the specialist
We turn trial results and papers into text that patients, carers, payers and the public can follow.
Plain-language summaries of publications
Summaries published alongside or after your paper.
- Journal-format PLS
- Stand-alone PLS articles
- Summaries of congress presentations
EU CTR lay summaries
Lay summaries of trial results for the EU Clinical Trials Information System.
- Structured to the regulation’s lay-summary content
- Written for a lay reading level
- Translated and localised into the languages you need
Visual abstracts and infographics
One-page visuals of the key result.
- Visual abstracts for journals and social media
- Infographics of trial design and results
- Accessible colour and text alternatives
Patient-facing trial results
Results communication for trial participants.
- Thank-you and results letters
- Website results pages
- Question-and-answer sheets
Readability-tested wording
Text measured, not guessed.
- Readability scores reported for each draft
- Jargon replaced or defined
- Numbers presented as natural frequencies
Source traceability
Every statement tied to the paper or report.
- Line-by-line source table
- No new claims beyond the source
- Second-writer check against the data
A summary you can defend line by line
Plain-language does not mean loose. Each summary arrives with the record that ties it to the source.
- Summary text: at the agreed reading level, with readability scores
- Source traceability table: every sentence linked to its place in the paper or report
- Glossary: terms the reader still needs, defined in plain words
- Figures: visual abstract or simple charts of the main result
- Reference check: citations verified against their DOIs
- Disclosure statement: funding and writing support stated as GPP 2022 requires
Readers outside medicine now read your results
Journals, regulators and patient groups increasingly expect results in plain language. A summary written loosely creates risk; one written to the source builds trust.
- EU CTR requires a lay summary of results for trials it covers
- Many journals now accept plain-language summaries with articles
- Patient organisations share plain-language results directly
- Plain language reaches payers and policymakers faster
- A traced summary avoids promotional or off-label wording
Try us free first
- A plain-language summary of one of your published papers
- Delivered with its readability scores and source table
- Free, under NDA, in 3 working days
From brief to delivery
Fixed scope, fixed fee and dates agreed in writing before work starts.
Send the brief
Tell us the deliverable, target and deadline. We sign your NDA before confidential file sharing.
Receive a reply within 24 hours
Scope, fee, your named writer and dated milestones.
Write and review
Three review rounds included. Fixes for our own errors are always free.
Deliver with the record
Final files plus the checklist, logs and QC record for the job.
Questions we are asked first
What is the difference between a plain-language summary and a lay summary?
A plain-language summary usually accompanies a publication. A lay summary under the EU Clinical Trials Regulation is a required summary of a trial’s results for the public. We write both.
Which journals accept plain-language summaries?
A growing number of journals and publishers accept them, either alongside the article or as a separate piece. We check your target journal’s policy before we write.
What reading level do you write to?
The level agreed with you for the audience, and we report readability scores for each draft so you can see it.
Can patients review the summary?
Yes. If you nominate patient reviewers, we build their review into the rounds and record their comments.
Can we try you before we pay?
Yes. Send one of your published papers and get a free plain-language summary under NDA in 3 working days.
Where client work is published
NeucitePress does not publish its writing clients’ work in NeucitePress journals or books. We recommend established third-party journals, typically from Elsevier, Springer Nature and Wiley, chosen for scope and indexing. You make every submission decision, and no one can promise acceptance.
Services and guides that go with this
Fixed prices for clinicians start at USD 650: see all prices. A scoped proposal follows within 24 hours of a complete brief.
See your paper in plain language, free
Free sample in 3 working days, NDA before confidential file sharing.
Try free: get a sample draft